That is what doctors will tell you. For
example, Dr. Paul Offit (from the The Greater Good - Think You
Know Everything About Vaccines... Think Again) says "...vaccines
should cause virtually no severe side effects and that's really
pretty much true... It is extremely rare that they would cause
any problems." Look at all the adverse reactions below... and
decide for yourself... if vaccine side effects are worth it...
Find the package insert that comes with the vaccine. Search the package insert for "adverse events reported" or "adverse reactions". If you want to know the brand name for a vaccine by any disease, search on "commercial name of vaccine for [disease]". Here is a list of the most common ones:
The Merck MMR vaccine is meant to
protect against measles (rubeola), mumps, and rubella. From
the MMR Package Insert, potential adverse side effects include:
"Body as a Whole (panniculitis; atypical measles; fever; syncope;
headache; dizziness; malaise; irritability). Cardiovascular System
(Vasculitis). Digestive System (Pancreatitis; diarrhea; vomiting;
parotitis; nausea). Endocrine System (Diabetes mellitus). Hemic
and Lymphatic System (Thrombocytopenia; purpura; regional
lymphadenopathy; leukocytosis). Immune System (Anaphylaxis and
anaphylactoid reactions have been reported as well as related
phenomena such as angioneurotic edema (including peripheral or
facial edema) and bronchial spasm in individuals with or without
an allergic history). Musculoskeletal System (Arthritis;
arthralgia; myalgia)...
Other (Death from various, and in some
cases unknown, causes has been reported rarely following
vaccination with measles, mumps, and rubella vaccines."
The Tripedia DTAP vaccine is meant to protect
against Diphtheria and Tetanus Toxoids and Pertussis. From the
Tripedia Dtap Package Insert, potential adverse side effects
include: "idiopathic thrombocytopenic purpura, SIDS, anaphylactic
reaction, cellulitis, autism, convulsion/grand mal convulsion,
encephalopathy, hypotonia, neuropathy, somnolence and apnea."
The Infanrix vaccine is meant to protect
against Diphtheria and Tetanus Toxoids and Pertussis. From the
Infanrix Package Insert, potential adverse side effects include:
"Rates of injection site reactions (pain, redness, swelling) ranged
from 10% to 53%, depending on reaction and dose number, and were
highest following Doses 4 and 5. Fever was common (20% to 30%)
following Doses 1-3. Other common solicited adverse events were
drowsiness, irritability/fussiness, and loss of appetite, reported
in approximately 15% to 60% of subjects, depending on event and
dose number."
The Gardasil vaccine is meant to protect
against diseases caused by Human Papillomavirus (HPV). From the
Gardasil Package Insert, potential adverse side effects include:
"Headache, fever, nausea, and dizziness; and local injection site
reactions (pain, swelling, erythema, pruritus, and bruising).
Syncope, sometimes associated with tonic-clonic movements and
other seizure-like activity and may result in falling with
injury; anaphylaxis."
The Varivax vaccine is meant to protect
against varicella (otherwise known as chicken pox). From the
Varivax Package Insert, potential adverse side effects include:
"(=10%) adverse reactions in children ages 1 to 12 years include:
• fever =102.0°F (38.9°C), oral: 14.7% • injection-site complaints:
19.3% (6.1); Frequently reported (=10%) adverse reactions in
adolescents and adults ages 13 years and older include: • fever =
100.0°F (37.8°C), oral: 10.2% • injection-site complaints: 24.4%
(6.1); Other reported adverse reactions in all age groups include:
• varicella-like rash (injection site) • varicella-like rash
(generalized)."
The Flu Mist vaccine is meant to protect
against influenza. From the Flu Mist Package Insert, potential
adverse side effects include: "-10% in vaccine recipients and
at least 5% greater than in placebo recipients) reported after
FluMist were runny nose or nasal congestion (ages 2 years through
49 years), fever over 100°F (children ages 2 years through 6 years),
and sore throat (adults ages 18 years through 49 years). Among
children and adolescents 2 through 17 years of age who received
FluMist Quadrivalent, 32% reported runny nose or nasal congestion
and 7% reported fever over 100°F. Among adults 18 through 49 years
of age who received FluMist Quadrivalent, 44% reported runny nose
or nasal congestion and 19% reported sore throat."
The Fluzone vaccine is meant to protect
against influenza. From the Fluzone Package Insert, potential
adverse side effects include: "• In children 6 months through
35 months of age, the most common (=10%) injection-site reactions
were pain (57%) or tenderness (54%), erythema (37%), and swelling
(22%); the most common solicited systemic adverse reactions were
irritability (54%), abnormal crying (41%), malaise (38%), drowsiness
(38%), appetite loss (32%), myalgia (27%), vomiting (15%), and
fever (14%). • In children 3 years through 8 years of age, the
most common (=10%) injection-site reactions were pain (67%),
erythema (34%), and swelling (25%); the most common solicited
systemic adverse reactions were myalgia (39%), malaise (32%),
and headache (23%). • In adults 18 years and older, the most
common (=10%) injection-site reaction was pain (47%); the most
common solicited systemic adverse reactions were myalgia (24%),
headache (16%), and malaise (11%). • In adults 65 years of age
and older, the most common (=10%) injection- site reaction was
pain (33%); the most common solicited systemic adverse reactions (11%)."
The Recombivax HB vaccine is meant to protect
against Hepatitis B virus. From the Recombivax HB Package Insert,
potential adverse side effects include: "GENERAL DISORDERS AND
ADMINISTRATION SITE CONDITIONS Injection site reactions consisting
principally of soreness, and including pain, tenderness, pruritus,
erythema, ecchymosis, swelling, warmth, nodule formation. In three
clinical studies, 434 doses of RECOMBIVAX HB, 5 mcg, were
administered to 147 healthy The most frequent systemic complaints
include fatigue/weakness; headache; fever (=100°F); malaise.
GASTROINTESTINAL DISORDERS Nausea; diarrhea RESPIRATORY, THORACIC
AND MEDIASTINAL DISORDERS Pharyngitis; upper respiratory infection
Incidence Less Than 1% of Injections GENERAL DISORDERS AND
ADMINISTRATION SITE CONDITIONS Sweating; achiness; sensation of
warmth; lightheadedness; chills; flushing GASTROINTESTINAL DISORDERS
Vomiting; abdominal pains/cramps; dyspepsia; diminished appetite
RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS Rhinitis; influenza;
cough NERVOUS SYSTEM DISORDERS Vertigo/dizziness; paresthesia 4 SKIN
AND SUBCUTANEOUS TISSUE DISORDERS Pruritus; rash (non-specified);
angioedema; urticaria MUSCULOSKELETAL AND CONNECTIVE TISSUE
DISORDERS Arthralgia including monoarticular; myalgia; back pain;
neck pain; shoulder pain; neck stiffness BLOOD AND LYMPHATIC
DISORDERS Lymphadenopathy PSYCHIATRIC DISORDERS Insomnia/disturbed
sleep EAR AND LABYRINTH DISORDERS Earache RENAL AND URINARY
DISORDERS Dysuria CARDIAC DISORDERS Hypotension."
The Engerix-B vaccine is meant to protect
against Hepatitis B virus. From the Engerix-B Package Insert,
potential adverse side effects include: "Infections and Infestations
(Herpes zoster, meningitis); Blood and Lymphatic System Disorders
(Thrombocytopenia); Immune System Disorders (Allergic reaction,
anaphylactoid reaction, anaphylaxis. An apparent hypersensitivity
syndrome (serum sickness-like) of delayed onset has been reported
days to weeks after vaccination, including: arthralgia/arthritis
(usually transient), fever, and dermatologic reactions such as
urticaria, erythema multiforme, ecchymoses, and erythema nodosum).
Nervous System Disorders (Encephalitis, encephalopathy, migraine,
multiple sclerosis, neuritis, neuropathy including hypoesthesia,
paresthesia, Guillain-Barré syndrome and Bell’s palsy, optic
neuritis, paralysis, paresis, seizures, syncope, transverse
myelitis); Eye Disorders (Conjunctivitis, keratitis, visual
disturbances); Ear and Labyrinth Disorders (Earache, tinnitus,
vertigo); Cardiac Disorders (Palpitations, tachycardia); Vascular
Disorders (Vasculitis); Respiratory, Thoracic, and Mediastinal
Disorders (Apnea, bronchospasm including asthma-like symptoms);
Gastrointestinal Disorders (Dyspepsia); Skin and Subcutaneous
Tissue Disorders (Alopecia, angioedema, eczema, erythema multiforme
including Stevens-Johnson syndrome, erythema nodosum, lichen planus,
purpura); Musculoskeletal and Connective Tissue Disorders
(Arthritis, muscular weakness)."
The Havrix vaccine is meant to protect
against Hepatitis A virus. From the Havrix Package Insert,
potential adverse side effects include: "Metabolism and Nutrition
Disorders: (Anorexia); Gastrointestinal Disorders: (Nausea);
General Disorders and Administration Site Conditions: (Fatigue,
fever >99.5°F (37.5°C), induration, redness, and swelling of the
injection site; malaise); Infections and Infestations: (Pharyngitis,
upper respiratory tract infections); Blood and Lymphatic System
Disorders: (Lymphadenopathy); Psychiatric Disorders: (Insomnia);
Nervous System Disorders: (Dysgeusia, hypertonia); Eye Disorders:
(Photophobia); Ear and Labyrinth Disorders: (Vertigo);
Gastrointestinal Disorders: (Abdominal pain, diarrhea, vomiting);
Skin and Subcutaneous Tissue Disorders: (Pruritus, rash, urticaria);
Musculoskeletal and Connective Tissue Disorders: (Arthralgia,
myalgia); General Disorders and Administration Site Conditions:
(Injection site hematoma)."
The Vaqta vaccine is meant to protect
against Hepatitis A virus. From the Vaqta Package Insert,
potential adverse side effects include: "Children — 12 through 23
months of age: injection-site pain/tenderness (37.0%), injection-
site erythema (21.2%), fever (16.4% when administered alone, and
27.0% when administered concomitantly); Children/Adolescents — 2
through 18 years of age: injection-site pain (18.7%); Adults — 19
years of age and older: injection-site pain, tenderness, or soreness
(67.0%), injection-site warmth (18.2%) and headache (16.1%); local
and/or systemic allergic reactions that occurred in -1% of over 10,
000 children/adolescents or adults in clinical trials regardless of
causality included: injection-site pruritus and/or rash; bronchial
constriction; asthma; wheezing; edema/swelling; rash; generalized
erythema; urticaria; pruritus; eye irritation/itching; dermatitis."
The Menhibrix vaccine is meant to protect
against Neisseria meningitidis serogroups C and Y and Haemophilus
influenzae type b (Hib). From the Menhibrix Package Insert,
potential adverse side effects include: "Rates of local injection
site pain, redness, and swelling ranged from 15% to 46% depending
on reaction and specific dose in schedule. Commonly reported
systemic events included irritability (62% to 71%), drowsiness (49%
to 63%), loss of appetite (30% to 34%), and fever (11% to 26%).
General Disorders and Administration Site Conditions: (Extensive
swelling of the vaccinated limb, injection site induration); Immune
System Disorders: (Allergic reactions (including anaphylactic and
anaphylactoid reactions), angioedema); Nervous System Disorders:
(Convulsions (with or without fever), hypotonic-hyporesponsive
episode, somnolence, syncope or vasovagal responses to injection);
Respiratory, Thoracic, and Mediastinal Disorders: (Apnea); Skin and
Subcutaneous Tissue Disorders: (Rash, urticaria)."
The Pediarix vaccine is meant to protect
against poliomyelitis (polio) along with other diseases. From the
Pediarix Package Insert, potential adverse side effects include:
"local injection site reactions (pain, redness, and swelling),
fever (=100.4°F), drowsiness, irritability/fussiness, and loss
of appetite."
The Prevnar vaccine is meant to protect
against pneumonia. From the Prevnar Package Insert, potential
adverse side effects include: • In infants and toddlers vaccinated
at 2, 4, 6, and 12-15 months of age in US clinical trials, the
most commonly reported solicited adverse reactions (-5%) were
irritability (-70%), injection site tenderness (-50%), decreased
appetite (-40%), decreased sleep (-40%), increased sleep (-40%),
fever (-20%), injection site redness (-20%), and injection site
swelling (-20%). • In children aged 5 through 17 years, the most
commonly reported solicited adverse reactions (-5%) were injection
site tenderness (-80%), injection site redness (-30%), injection
site swelling (-30%), irritability (-20%), decreased appetite
(-20%), increased sleep (-20%), fever (-5%), and decreased sleep
(-5%). • In adults aged 18 years and older, the most commonly
reported solicited adverse reactions (-5%) were pain at the
injection site (-50%), fatigue (-30%), headache (-20%), muscle
pain (-20%), joint pain (-10%), decreased appetite (-10%),
injection site redness (-10%), injection site swelling (-10%),
limitation of arm movement (-10%), vomiting (-5%), fever (-5%),
chills (-5%),and rash (-5%)."
The BioThrax vaccine is meant to protect
against anthrax. From the Prevnar Package Insert, potential
adverse side effects include: "most common (-10%) local (injection-site)
adverse reactions observed in clinical studies were tenderness, pain,
erythema, edema, and arm motion limitation. The most common
(-5%) systemic adverse reactions were muscle aches, headache,
and fatigue."